Co-Diagnostics, Inc. Quarterly Deferred Tax Assets, Gross in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Co-Diagnostics, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2019 to Q4 2023.
  • Co-Diagnostics, Inc. Deferred Tax Assets, Gross for the quarter ending December 31, 2023 was $15.3M, a 197% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $15.3M +$10.1M +197% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $5.14M +$4.58M +819% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $560K -$343K -38% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $903K -$4.26M -82.5% Dec 31, 2020 10-K 2022-03-24
Q4 2019 $5.16M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.